Affordable Access

deepdyve-link
Publisher Website

Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors
  • Candotti, Fabio1, 2
  • 1 Division of Immunology and Allergy, University Hospital of Lausanne, Lausanne, Switzerland. [email protected] , (Switzerland)
  • 2 IAL, CHUV, BH10.527, Rue du Bugnon 46, 1011, Lausanne, Switzerland. [email protected] , (Switzerland)
Type
Published Article
Journal
Journal of Clinical Immunology
Publisher
Springer-Verlag
Publication Date
Oct 30, 2017
Identifiers
DOI: 10.1007/s10875-017-0453-z
PMID: 29086100
Source
Medline
Keywords
License
Unknown

Abstract

The Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder originally described by Dr. Alfred Wiskott in 1937 and Dr. Robert Aldrich in 1954 as a familial disease characterized by infections, bleeding tendency, and eczema. Today, it is well recognized that the syndrome has a wide clinical spectrum ranging from mild, isolated thrombocytopenia to full-blown presentation that can be complicated by life-threatening hemorrhages, immunodeficiency, atopy, autoimmunity, and cancer. The pathophysiology of classic and emerging features is being elucidated by clinical studies, but remains incompletely defined, which hinders the application of targeted therapies. At the same time, progress of hematopoietic stem cell transplantation and gene therapy offer optimistic prospects for treatment options aimed at the replacement of the defective lymphohematopoietic system that have the potential to provide a cure for this rare and polymorphic disease.

Report this publication

Statistics

Seen <100 times